This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

COVID-19 Saliva Sampling Test Potential Market

Market Insights on COVID-19 Saliva Sampling Test Potential covering sales outlook, demand forecast & up-to-date key trends

COVID-19 Saliva Sampling Test Potential Market by Location, Technology, Mode & Region - Forecast 2022 – 2032

COVID-19 Saliva Sampling Test Potential Market Snapshot (2022-2032)

[250 Pages Report] Newly released COVID-19 Saliva Sampling Test Potential Market analysis report by Future Market Insights shows that global sales of COVID-19 Saliva Sampling Test Potential Market in 2021 were held at US$ 3.1 Bn. With 5.1%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth. Fluorescence-labeled antigen/antibodies testing is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 5.1% during 2022 – 2032.

Attributes

Details

Covid-19 Saliva Sampling Test Potential Market CAGR (2022 – 2032)

5.1%

Covid-19 Saliva Sampling Test Potential Market Size (2022)

US$ 3.3 Bn

Covid-19 Saliva Sampling Test Potential Market Size (2032)

US$ 5.4 Bn

Customize this Report

Let us know your requirement to get
100% FREE customization

Revenue of COVID-19 Saliva Sampling Test Potential Market from 2019 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the COVID-19 Saliva Sampling Test Potential Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2019 to 2021, market value of the COVID-19 Saliva Sampling Test Potential Market increased at around 4.3% CAGR.

In the next few years, concerns about the spread of a SARS-CoV-2 variant are expected to raise the necessity for comprehensive Sampling and surveillance techniques that will be followed by an increase in demand for COVID-19 saliva Sampling tests. This is likely to lead to an increase in demand for COVID-19 saliva Sampling test potential between the years 2022 and 2032.

As the cases of people visiting public places grow, visitors have begun to predominate in some locations worldwide, leading to an increase in demand for testing at point-of-care to determine whether a person is contagious with the coronavirus disease (COVID-19). This has fuelled technological innovation, which is spurring improvements in the sequencing of saliva-based diagnostic tests to prevent viral transmission from asymptomatic individuals.

Fluorescence-labelled antigen/antibody testing allows for the rapid identification of contagious individuals and is an effective Sampling modality for cruise ships, aeroplanes, sports stadiums, and schools. The combination of vaccination and rapid and frequent testing with fluorescence-labelled antigen/antibodies tests has the potential to end the pandemic. The system for fluorescence-labelled antigen/antibody testing is intended to accelerate rapid point-of-access testing of individuals by utilizing the principles of fluorescence detection, biochemistry, robotics automation, and cloud computing.

Owing to the physiological changes associated with ageing and potential underlying health conditions, the ageing population is at a high risk of developing severe illness. Poor health status, decreased organ function, weakened immune function, an increased likelihood of multiple underlying diseases, and a lack of attention to personal health can all increase susceptibility to various diseases in the elderly. As a result, the growing population of people over the age of 65 indicates that a greater proportion of people in this age group are at risk of contracting the disease. As a result, the ageing population is more vulnerable to viral infections, which will increase demand for COVID-19 saliva-based Sampling.

According to a study conducted in 2020, 23,487 fatality cases were reported in a population of 25 million men over the age of 65, while 2,765 fatality cases were reported in a population of 31 million women over the age of 65 in the United States. The new COVID-19 saliva test is thought to make testing easier for people of all ages because the saliva-based method allows for simpler and faster sample collection.

  • COVID-19 Saliva Sampling Test Potential Market was valued at US$ 3.1 Bn in 2021. According to Future Market Insights, COVID-19 Saliva Sampling Test Potential Market revenue would increase 1.6X between 2022 and 2032, reaching roughly US$ 5.4 Bn in 2032.
  • In terms of Technology, the Fluorescence-labelled antigen/antibodies Testing accounts for the highest projected CAGR of over 5.1%.
  • In terms of Modes of COVID-19 Saliva Sampling Test Potential, Centralized Testing accounts for the highest CAGR of 5.1% during the historic period (2019-21).
  • US is the dominant region in COVID-19 Saliva Sampling Test Potential Market with an absolute dollar growth opportunity of over US$ 1.7 Bn.

Which Factors are Propelling COVID-19 Saliva Sampling Test Potential Demand?

The timeline and cost constraints on molecular swab-based SARS-CoV-2 Sampling are prompting customers to shift to saliva-based testing to screen for the virus, which is driving market growth. The emergence of SARS-CoV-2 variants in South Africa, the United Kingdom, and Brazil, which stemmed from radical Islam, drives people toward greater testing to quickly detect emerging strains. Concerns about the widespread nature of these variants are expected to fuel demand for surveillance and testing among the general public.

In these programmes, the Fluorescence-labelled antigen/antibody testing Pandemic Défense Platform was found to be effective. Vaccine administration alone is unlikely to be sufficient; mass Sampling will be required for businesses to reopen.

Shorter testing times, user-friendliness, and a patient-friendly nature are just a few of the factors driving this test's growing popularity. These factors are apt to help contribute to the growth in the COVID-19 saliva Sampling test potential market in the coming years. Despite high market penetration and continued scientific development, the challenges associated with the methodology of swab-based testing are likely to hold market growth back.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the most promising opportunities for COVID-19 Saliva-based Sampling Product Manufacturers?

Owing to the virus's outbreak and rapid spread, countries have imposed mandatory guidelines for COVID-19 diagnostics and other activities such as travel. Many countries have made it mandatory to have a negative COVID-19 test in order to travel internationally or domestically.

Furthermore, in order to break the chain, government guidelines have included testing of people who may have come into contact with infected people. The increase in the number of tests as a result of government standards and guidelines represents significant growth opportunities for COVID-19 saliva-based Sampling.

Region-wise Analysis

Which Region is projected to Offer the Largest Opportunity for COVID-19 Saliva Sampling Test Potential Market?

In 2021, North America accounted for the largest proportion of revenue in the worldwide COVID-19 Saliva Sampling Test Potential market. It is expected to continue maintaining a significant portion over the forecast period. New products introduced by emerging start-ups have led to the emergence of home grown businesses developing and manufacturing processes for a variety of diagnostic tests and Sampling tools. The growth of this vital industry is contributing to the area's economic dominance.

The ICAO Air Transport Bureau expects that there will be an overall decrease in airline passengers of up to 60% in 2020. Revenue from airline in North America was reduced by US$ 88 Bn. This indicates that the North American region has a high potential for economic growth by using saliva-based COVID-19 Sampling tests.

Which Region is estimated to be the Fastest-growing COVID-19 Saliva Sampling Test Potential Market during the Forecast Period?

Considerations for using saliva as a diagnostic tool to detect COVID-19 were identified in May 2021 by the European Centre for Disease Prevention and Control. According to this report, commercial tests based on saliva specimens are legal in the European Union and are marked CE.

The European Medicines Agency (EMA) has granted various companies authorizations for their marketing of their products in Europe, thereby increasing the market potential for saliva-based Sampling tools in this region. Also, increasing awareness about the use of saliva-based Sampling tests in order to circumvent the spread of COVID-19 and changing lifestyles will lead to an increase in market growth in Europe.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Analysis

Which Country Lies at the CenterStage for COVID-19 Saliva Sampling Test Potential Market Revenue?

The United States is expected to have the highest market share of US$ 4.4 Bn by the end of 2032. The FDA is critical in safeguarding the country’s population from newer infectious disease threats such as the COVID-19 outbreak. The FDA is committed to provide appropriate guidance to support response efforts to the COVID-19 pandemic, which is expected to benefit market growth in the United States.

Category-wise Insights

Why Fluorescence-labelled antigen/antibodies Testing is projected to WiBness Fastest Growth among COVID-19 Saliva Sampling Test Potential Technology?

Fluorescence-labelled antigen/antibodies Testing segment is forecasted to grow at the highest CAGR of over 5.1% during 2022-2032. Fluorescence-labelled antigen/antibody testing is well-suited for a high-traffic, high-risk pandemic ecosystem, which includes manufacturing facilities, hospitals and large healthcare facilities, corporate campuses, athletic stadiums, transportation and distribution hubs, schools and colleges, shopping centres, performance venues, airline and cruise ship terminals, and other large business and retail settings. As a result, the saliva-based COVID-19 Sampling market has a lot of room to grow in the near future.

Which Mode of COVID-19 Saliva Sampling Test Potential is expected to Score Highest Growth in the Coming Years?

Centralized Testing commanded the highest price as well as CAGR of 5.1% from the period 2012 to 2023, whereas centralised testing held in the medical sector was the fastest growing segment of the market. As diagnostic tests are often carried out in a centralised method, legislation that would mandate its execution could be hugely profitable.

The main principle of saliva-based COVID-19 diagnosis by centralised settings is the ease of sample collection. The minimized need for specimen collection reduces the volume of collection supplies that have been required for diagnostic saliva testing. Fewer tests are required in the testing protocol. Furthermore, laboratories have access to diagnostic testing machines.

Competitive Analysis

Players in the market are constantly developing innovative solutions as well as extending their product offerings. To help healthcare organisations implement data analysis solutions, combat the Covid-19 pandemic, and preserve competitive advantage in the market, the companies are focused on their alliances, technology collaborations, and product launch strategies.

Some of the recent developments of key COVID-19 Saliva Sampling Test Potential providers are as follows:

  • In April 2021, Chembio Diagnostics, Inc. developed a rapid POCT licensed for use in both decentralized and traditional diagnostic laboratories in response to orders for COVID-19 tests. This product's stock was immediately available for the construction of customers throughout the U.S.
  • In April 2021, Vatic Health received the CE mark for its on-the-spot SARS-CoV-2 virus saliva antigen test. The test has also been registered with the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom.
  • In March 2020, ID NOW, a molecular POCT for detecting novel coronavirus (COVID-19), was launched by Abbott after receiving an Emergency Use Authorization from the U.S. Food and Drug Administration (EUA). It is small, lightweight (6.6 pounds), and portable (the size of a small toaster), and it employs molecular technology to produce positive results in as little as five minutes and negative results in as little as 13 minutes.

Similarly, recent developments related to companies COVID-19 Saliva Sampling Test Potential services have been tracked by the team at Future Market Insights, which are available in the full report.

COVID-19 Saliva Sampling Test Potential Market Report Scope

Attribute

Details

Forecast Period

2022-2032

Historical Data Available for

2019-2021

Market Analysis

US$ Bn for Value

Key Regions Covered

North America, Latin America, Europe, Asia Pacific, Middle East & Africa

Key Countries Covered

United States, Canada, Brazil, Mexico, Germany, U.K., France, Spain, Italy, Russia, China, Japan, South Korea, India, Australia, South Africa, Saudi Arabia, UAE and Israel.

Key Market Segments Covered

Location, Technology, Mode and Region

Key Companies Profiled

Pricing

Available upon Request

Market Segments Covered in COVID-19 Saliva Sampling Test Potential Market Analysis

By Location:

  • Travel Stations
  • Sports Arenas
  • Entertainment Venues
  • Corporate Campus Environments
  • Universities & Colleges
  • Factories

By Technology:

  • Fluorescence-labeled antigen/antibodies testing
  • RT-PCR
  • CRISPR-Cas9

By Mode:

  • Centralized Testing
  • Decentralized Testing

By Region:

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Frequently Asked Questions

The global COVID-19 Saliva Sampling Test Potential Market is worth more than US$ 3.3 Bn at present.

Value of COVID-19 Saliva Sampling Test Potential Market are projected to increase at a CAGR of around 5.1% during 2022 – 2032.

Value of COVID-19 Saliva Sampling Test Potential Market increased at a CAGR of around 4.3% during 2019 – 2021.

Several major players are concentrating on advancements in in-vitro diagnostic procedures with rapid testing, as well as expanding their product portfolios.

The market for COVID-19 Saliva Sampling Test Potential Market in China is projected to expand at a CAGR of around 5.2% during 2022 – 2032.

While the market in South Korea is expected to grow at nearly 4.3%, the market in Japan is projected to register a CAGR of nearly 4.2% during 2022 - 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

4. Global COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Location

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Location, 2019-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Location, 2022-2032

        5.3.1. Travel Stations

        5.3.2. Sports Arenas

        5.3.3. Entertainment Venues

        5.3.4. Corporate Campus Environment

        5.3.5. Universities & Colleges

        5.3.6. Factories

    5.4. Y-o-Y Growth Trend Analysis By Location, 2019-2021

    5.5. Absolute $ Opportunity Analysis By Location, 2022-2032

6. Global COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Technology

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2019-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032

        6.3.1. Fluorescent-labeled antigen/ antibodies Testing

        6.3.2. RT-PCR

        6.3.3. CRISPR-Cas9

    6.4. Y-o-Y Growth Trend Analysis By Technology, 2019-2021

    6.5. Absolute $ Opportunity Analysis By Technology, 2022-2032

7. Global COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Mode

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By Mode, 2019-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Mode, 2022-2032

        7.3.1. Centralized Testing

        7.3.2. Decentralized Testing

    7.4. Y-o-Y Growth Trend Analysis By Mode, 2019-2021

    7.5. Absolute $ Opportunity Analysis By Mode, 2022-2032

8. Global COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Location

        9.2.3. By Technology

        9.2.4. By Mode

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Location

        9.3.3. By Technology

        9.3.4. By Mode

    9.4. Key Takeaways

10. Latin America COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Location

        10.2.3. By Technology

        10.2.4. By Mode

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Location

        10.3.3. By Technology

        10.3.4. By Mode

    10.4. Key Takeaways

11. Europe COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. Italy

            11.2.1.3. France

            11.2.1.4. U.K.

            11.2.1.5. Spain

            11.2.1.6. Russia

            11.2.1.7. BENELUX

            11.2.1.8. Rest of Europe

        11.2.2. By Location

        11.2.3. By Technology

        11.2.4. By Mode

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Location

        11.3.3. By Technology

        11.3.4. By Mode

    11.4. Key Takeaways

12. Asia Pacific COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. India

            12.2.1.5. Rest of Asia Pacific

        12.2.2. By Location

        12.2.3. By Technology

        12.2.4. By Mode

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Location

        12.3.3. By Technology

        12.3.4. By Mode

    12.4. Key Takeaways

13. MEA COVID-19 Saliva Sampling Test Potential Market Analysis 2019-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. GCC

            13.2.1.2. Rest of MEA

        13.2.2. By Location

        13.2.3. By Technology

        13.2.4. By Mode

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Location

        13.3.3. By Technology

        13.3.4. By Mode

    13.4. Key Takeaways

14. Key Countries COVID-19 Saliva Sampling Test Potential Market Analysis

    14.1. U.S.

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2021

            14.1.2.1. By Location

            14.1.2.2. By Technology

            14.1.2.3. By Mode

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2021

            14.2.2.1. By Location

            14.2.2.2. By Technology

            14.2.2.3. By Mode

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2021

            14.3.2.1. By Location

            14.3.2.2. By Technology

            14.3.2.3. By Mode

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2021

            14.4.2.1. By Location

            14.4.2.2. By Technology

            14.4.2.3. By Mode

    14.5. Argentina

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2021

            14.5.2.1. By Location

            14.5.2.2. By Technology

            14.5.2.3. By Mode

    14.6. Germany

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2021

            14.6.2.1. By Location

            14.6.2.2. By Technology

            14.6.2.3. By Mode

    14.7. Italy

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2021

            14.7.2.1. By Location

            14.7.2.2. By Technology

            14.7.2.3. By Mode

    14.8. France

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2021

            14.8.2.1. By Location

            14.8.2.2. By Technology

            14.8.2.3. By Mode

    14.9. U.K.

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2021

            14.9.2.1. By Location

            14.9.2.2. By Technology

            14.9.2.3. By Mode

    14.10. Spain

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2021

            14.10.2.1. By Location

            14.10.2.2. By Technology

            14.10.2.3. By Mode

    14.11. Russia

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2021

            14.11.2.1. By Location

            14.11.2.2. By Technology

            14.11.2.3. By Mode

    14.12. BENELUX

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2021

            14.12.2.1. By Location

            14.12.2.2. By Technology

            14.12.2.3. By Mode

    14.13. China

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2021

            14.13.2.1. By Location

            14.13.2.2. By Technology

            14.13.2.3. By Mode

    14.14. Japan

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2021

            14.14.2.1. By Location

            14.14.2.2. By Technology

            14.14.2.3. By Mode

    14.15. South Korea

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2021

            14.15.2.1. By Location

            14.15.2.2. By Technology

            14.15.2.3. By Mode

    14.16. India

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2021

            14.16.2.1. By Location

            14.16.2.2. By Technology

            14.16.2.3. By Mode

    14.17. GCC Countries

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2021

            14.17.2.1. By Location

            14.17.2.2. By Technology

            14.17.2.3. By Mode

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Location

        15.3.3. By Technology

        15.3.4. By Mode

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. ARUP Laboratories

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segment

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. Vatic Health

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segment

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. Mogene

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segment

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. Psomagen Inc.

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segment

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. DxTerity Diagnostics Inc.

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segment

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. Chemibo Diagnostics

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segment

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. Abbott

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segment

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Region, 2019-2032

Table 2: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Location, 2019-2032

Table 3: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Technology, 2019-2032

Table 4: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Mode, 2019-2032

Table 5: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Country, 2019-2032

Table 6: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Location, 2019-2032

Table 7: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Technology, 2019-2032

Table 8: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Mode, 2019-2032

Table 9: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Country, 2019-2032

Table 10: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Location, 2019-2032

Table 11: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Technology, 2019-2032

Table 12: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Mode, 2019-2032

Table 13: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Country, 2019-2032

Table 14: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Location, 2019-2032

Table 15: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Technology, 2019-2032

Table 16: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Mode, 2019-2032

Table 17: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Country, 2019-2032

Table 18: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Location, 2019-2032

Table 19: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Technology, 2019-2032

Table 20: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Mode, 2019-2032

Table 21: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Country, 2019-2032

Table 22: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Location, 2019-2032

Table 23: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Technology, 2019-2032

Table 24: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Forecast by Mode, 2019-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Location, 2022-2032

Figure 2: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Technology, 2022-2032

Figure 3: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Mode, 2022-2032

Figure 4: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Region, 2019-2032

Figure 6: Global COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Location, 2019-2032

Figure 9: Global COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Location, 2022-2032

Figure 10: Global COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Location, 2022-2032

Figure 11: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Technology, 2019-2032

Figure 12: Global COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 13: Global COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 14: Global COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Mode, 2019-2032

Figure 15: Global COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Mode, 2022-2032

Figure 16: Global COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Mode, 2022-2032

Figure 17: Global COVID-19 Saliva Sampling Test Potential Market Attractiveness by Location, 2022-2032

Figure 18: Global COVID-19 Saliva Sampling Test Potential Market Attractiveness by Technology, 2022-2032

Figure 19: Global COVID-19 Saliva Sampling Test Potential Market Attractiveness by Mode, 2022-2032

Figure 20: Global COVID-19 Saliva Sampling Test Potential Market Attractiveness by Region, 2022-2032

Figure 21: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Location, 2022-2032

Figure 22: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Technology, 2022-2032

Figure 23: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Mode, 2022-2032

Figure 24: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Country, 2019-2032

Figure 26: North America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Location, 2019-2032

Figure 29: North America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Location, 2022-2032

Figure 30: North America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Location, 2022-2032

Figure 31: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Technology, 2019-2032

Figure 32: North America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 33: North America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 34: North America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Mode, 2019-2032

Figure 35: North America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Mode, 2022-2032

Figure 36: North America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Mode, 2022-2032

Figure 37: North America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Location, 2022-2032

Figure 38: North America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Technology, 2022-2032

Figure 39: North America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Mode, 2022-2032

Figure 40: North America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Country, 2022-2032

Figure 41: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Location, 2022-2032

Figure 42: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Technology, 2022-2032

Figure 43: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Mode, 2022-2032

Figure 44: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Country, 2019-2032

Figure 46: Latin America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Location, 2019-2032

Figure 49: Latin America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Location, 2022-2032

Figure 50: Latin America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Location, 2022-2032

Figure 51: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Technology, 2019-2032

Figure 52: Latin America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 53: Latin America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 54: Latin America COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Mode, 2019-2032

Figure 55: Latin America COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Mode, 2022-2032

Figure 56: Latin America COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Mode, 2022-2032

Figure 57: Latin America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Location, 2022-2032

Figure 58: Latin America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Technology, 2022-2032

Figure 59: Latin America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Mode, 2022-2032

Figure 60: Latin America COVID-19 Saliva Sampling Test Potential Market Attractiveness by Country, 2022-2032

Figure 61: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Location, 2022-2032

Figure 62: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Technology, 2022-2032

Figure 63: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Mode, 2022-2032

Figure 64: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Country, 2019-2032

Figure 66: Europe COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Location, 2019-2032

Figure 69: Europe COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Location, 2022-2032

Figure 70: Europe COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Location, 2022-2032

Figure 71: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Technology, 2019-2032

Figure 72: Europe COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 73: Europe COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 74: Europe COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Mode, 2019-2032

Figure 75: Europe COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Mode, 2022-2032

Figure 76: Europe COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Mode, 2022-2032

Figure 77: Europe COVID-19 Saliva Sampling Test Potential Market Attractiveness by Location, 2022-2032

Figure 78: Europe COVID-19 Saliva Sampling Test Potential Market Attractiveness by Technology, 2022-2032

Figure 79: Europe COVID-19 Saliva Sampling Test Potential Market Attractiveness by Mode, 2022-2032

Figure 80: Europe COVID-19 Saliva Sampling Test Potential Market Attractiveness by Country, 2022-2032

Figure 81: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Location, 2022-2032

Figure 82: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Technology, 2022-2032

Figure 83: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Mode, 2022-2032

Figure 84: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Country, 2022-2032

Figure 85: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Country, 2019-2032

Figure 86: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Location, 2019-2032

Figure 89: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Location, 2022-2032

Figure 90: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Location, 2022-2032

Figure 91: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Technology, 2019-2032

Figure 92: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 93: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 94: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Mode, 2019-2032

Figure 95: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Mode, 2022-2032

Figure 96: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Mode, 2022-2032

Figure 97: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Attractiveness by Location, 2022-2032

Figure 98: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Attractiveness by Technology, 2022-2032

Figure 99: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Attractiveness by Mode, 2022-2032

Figure 100: Asia Pacific COVID-19 Saliva Sampling Test Potential Market Attractiveness by Country, 2022-2032

Figure 101: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Location, 2022-2032

Figure 102: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Technology, 2022-2032

Figure 103: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Mode, 2022-2032

Figure 104: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) by Country, 2022-2032

Figure 105: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Country, 2019-2032

Figure 106: MEA COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: MEA COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Location, 2019-2032

Figure 109: MEA COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Location, 2022-2032

Figure 110: MEA COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Location, 2022-2032

Figure 111: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Technology, 2019-2032

Figure 112: MEA COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 113: MEA COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 114: MEA COVID-19 Saliva Sampling Test Potential Market Value (US$ Mn) Analysis by Mode, 2019-2032

Figure 115: MEA COVID-19 Saliva Sampling Test Potential Market Value Share (%) and BPS Analysis by Mode, 2022-2032

Figure 116: MEA COVID-19 Saliva Sampling Test Potential Market Y-o-Y Growth (%) Projections by Mode, 2022-2032

Figure 117: MEA COVID-19 Saliva Sampling Test Potential Market Attractiveness by Location, 2022-2032

Figure 118: MEA COVID-19 Saliva Sampling Test Potential Market Attractiveness by Technology, 2022-2032

Figure 119: MEA COVID-19 Saliva Sampling Test Potential Market Attractiveness by Mode, 2022-2032

Figure 120: MEA COVID-19 Saliva Sampling Test Potential Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

COVID-19 Saliva Sampling Test Potential Market